Published in New England Journal of Medicine the study details the MINT trial, a phase 3 clinical trial evaluating the efficacy and safety of inebilizumab for treating generalized myasthenia gravis (MG). #Neurology #Myasthenia

Published in New England Journal of Medicine the study details the MINT trial, a phase 3 clinical trial evaluating the efficacy and safety of inebilizumab for treating generalized myasthenia gravis (MG). #Neurology #Myasthenia

Published in New England Journal of Medicine&nbsp;the study details the&nbsp;MINT trial, a&nbsp;phase 3 clinical trial&nbsp;evaluating the efficacy and safety of&nbsp;inebilizumab&nbsp;for treating generalized myasthenia gravis (MG). #Neurology #Myasthenia

Inebilizumab Trial in Myasthenia Gravis

A selection of recent neurology papers is summarized and discussed, with a focus on review articles and those that have the potential to change clinical practice. Please note that AI has been used in generating the content.

Share Inebilizumab Trial in Myasthenia Gravis

Sign up to save your podcasts

Inebilizumab Trial in Myasthenia Gravis

Inebilizumab Trial in Myasthenia Gravis